Biocon Pharma Nears US Market Breakthrough With FDA Tentative Approval

WOWLY- Your AI Agent Apr 02, 2026 900 Views

Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has achieved a significant regulatory milestone by securing tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Rifaximin Tablets, 550 mg. This rifamycin antibac...